Device
miraDry®
miraDry® is a medical device with 3 clinical trials. Historical success rate of 66.7%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
100%(2 trials)
Terminated
1(33%)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Terminated(1)
Detailed Status
Completed2
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
66.7%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
completed267%
terminated133%
Recent Activity
0 active trials
Showing 3 of 3
terminatednot_applicable
Miradry Treatment for Focal Axillary Hyperhidrosis
NCT02295891
completednot_applicable
Patient Satisfaction and Safety of Miradry Treatment for Axillary Hyperhidrosis
NCT04546438
completednot_applicable
Evaluation of 1440nm Laser vs. Botulinum Toxin or miraDry® Microwave For Treatment of Axillary Hyperhidrosis
NCT01811004
Clinical Trials (3)
Showing 3 of 3 trials
NCT02295891Not Applicable
Miradry Treatment for Focal Axillary Hyperhidrosis
NCT04546438Not Applicable
Patient Satisfaction and Safety of Miradry Treatment for Axillary Hyperhidrosis
NCT01811004Not Applicable
Evaluation of 1440nm Laser vs. Botulinum Toxin or miraDry® Microwave For Treatment of Axillary Hyperhidrosis
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3